American Shared Hospital Services
$1.41
0%
2026-04-21 05:17:00
ashs.com
ASE: AMS
Explore American Shared Hospital Services stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$9.46 M
Current Price
$1.41
52W High / Low
$3.11 / $1.25
Stock P/E
—
Book Value
$3.65
Dividend Yield
—
ROCE
-6.29%
ROE
-9.45%
Face Value
—
EPS
$-0.23
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
—
Beta
0.29
Debt / Equity
78.27
Current Ratio
0.76
Quick Ratio
0.76
Forward P/E
3.38
Price / Sales
0.32
Enterprise Value
$30.78 M
EV / EBITDA
8.32
EV / Revenue
1.1
Rating
None
Target Price
$4.5
EPS Forecast (FY)
—
Pros
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Option Care Health, Inc. | $28.77 | 21.68 | $4.5 B | — | 12.87% | 15.2% | $36.8 / $24.24 | $8.46 |
| 2. | The Pennant Group, Inc. | $29.64 | 35.03 | $1.04 B | — | 6.2% | 9.84% | $35 / $21.73 | $9.54 |
| 3. | Universal Health Services, Inc. | $180.51 | 7.82 | $11.04 B | 0.45% | 16.23% | 21.33% | $246.32 / $152.33 | $119.15 |
| 4. | Nutex Health Inc. | $109.28 | 11.86 | $761.5 M | 9.75% | 36.24% | 58.94% | $193.07 / $77.21 | $46.49 |
| 5. | Cryo-Cell International, Inc. | $3.56 | — | $27.71 M | 11.63% | 11.54% | 15.27% | $6.35 / $2.72 | $-2.31 |
| 6. | Tenet Healthcare Corporation | $189.93 | 12.26 | $16.56 B | — | 13.64% | 27.02% | $247.21 / $109.82 | $48.53 |
| 7. | NewGenIvf Group Limited | $2.19 | 0.08 | $1.32 M | — | -135.35% | 79.4% | $7,356 / $1.52 | $110.5 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 7.73 M | 7.17 M | 7.07 M | 6.11 M | 9.07 M | — |
| Operating Profit | -1.08 M | 0.05 M | -0.12 M | -0.87 M | 1.5 M | — |
| Net Profit | -0.63 M | -0.02 M | -0.28 M | -0.62 M | -1.33 M | — |
| EPS in Rs | -0.1 | -0 | -0.04 | -0.09 | -0.2 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 28.08 M | 28.34 M | 21.32 M | 19.75 M |
| Operating Profit | -2.01 M | 1.78 M | 2.32 M | 3.24 M |
| Net Profit | -1.55 M | 2.19 M | 0.61 M | 1.33 M |
| EPS in Rs | -0.24 | 0.33 | 0.09 | 0.2 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 55.48 M | 60.2 M | 48.16 M | 43.96 M |
| Total Liabilities | 27.79 M | 30.17 M | 21.88 M | 18.33 M |
| Equity | 24.03 M | 25.18 M | 22.62 M | 21.62 M |
| Current Assets | 17.72 M | 26.26 M | 20.46 M | 18.72 M |
| Current Liabilities | 23.44 M | 10.4 M | 10.78 M | 5.17 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 3.1 M | 0.17 M | 5.72 M | 7.24 M |
| Investing CF | -7.63 M | -7.11 M | -6.27 M | -0.39 M |
| Financing CF | -3.03 M | 4.41 M | 1.91 M | -2.66 M |
| Free CF | -4.54 M | -7.77 M | -0.56 M | 6.85 M |
| Capex | -7.63 M | -7.94 M | -6.27 M | -0.39 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 32.9% | 8% | — | — |
| Earnings Growth % | 258.36% | -54.07% | — | — |
| Profit Margin % | 7.71% | 2.86% | 6.73% | — |
| Operating Margin % | 6.27% | 10.89% | 16.39% | — |
| Gross Margin % | 32.41% | 43.82% | 42.45% | — |
| EBITDA Margin % | 31.44% | 32.7% | 41.06% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.